ICD is triggered after the release and expression, within the tumor-microenvironment, of tumor-derived bioactive molecules that lead to the activation of resident dendritic cells (DCs) and their further cross-priming of CD8+ T cells which play a pivotal role in tumor eradication [8]. The gene discussed is CD8A; the disease is neoplasm.